Cutler Group LLC / CA - CTI BIOPHARMA CORP ownership

Back to all holdings Add to watchlist

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 133 filers reported holding CTI BIOPHARMA CORP in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q4 2022$2
-100.0%
4,500
-0.9%
0.00%–
Q3 2022$5,000
-95.4%
4,540
-85.0%
0.00%
-100.0%
Q2 2022$109,000
-49.5%
30,205
-65.4%
0.01%
-27.3%
Q1 2022$216,000
+7100.0%
87,219
+11024.9%
0.01%–
Q1 2017$3,000–784–0.00%–
 Download
Other shareholders
CTI BIOPHARMA CORP shareholders Q1 2023
NameSharesValueWeighting ↓
Legal & General Group Plc 9,340$84,9010.00%
UBS ASSET MANAGEMENT AMERICAS INC 92,700$389,3400.00%
FNY Investment Advisers, LLC 20$00.00%
View complete list of CTI BIOPHARMA CORP shareholders